Jazz Pharmaceuticals plc (JAZZ) Financials

JAZZ Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 11.3 billion 7.6 billion
2023-12-31 11.4 billion 7.7 billion
2023-09-30 11.2 billion 7.7 billion
2023-06-30 11.3 billion 7.7 billion

JAZZ Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 250.3 million 61.4 million
2023-12-31 157.2 million 52.9 million
2023-09-30 302.9 million 56.1 million
2023-06-30 291.0 million 61.4 million

JAZZ Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 -14.6 million
2023-12-31 94.2 million
2023-09-30 146.8 million
2023-06-30 104.4 million

JAZZ Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 - - 74.5 million
2023-12-31 1.6 billion - 78.7 million
2023-09-30 1.6 billion - 78.6 million
2023-06-30 1.4 billion 5.7 billion 82.5 million

JAZZ Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 63.0 million
2023-12-31 69.7 million
2023-09-30 71.3 million
2023-06-30 73.5 million

JAZZ Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 16.9 million 222.8 million 351.7 million -
2023-12-31 10.1 million 216.6 million 396.0 million -
2023-09-30 4.3 million 234.4 million 308.3 million -
2023-06-30 5.7 million 209.2 million 340.8 million -

JAZZ Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 902.0 million 95.5 million
2023-12-31 1.0 billion 258.8 million
2023-09-30 972.1 million 102.2 million
2023-06-30 957.3 million 97.5 million

JAZZ

Price: $105.25

52 week price:
103.01
146.70

Payout Ratio Range:
2.89%
9.72%

Earnings Per Share: 4.83 USD

P/E Ratio: 144.80

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 468012

Ebitda: 136.8 million

Market Capitalization: 6.9 billion

Links: